Stuart D. Shanler, MD/FAAD/FACMS
Aclaris Therapeutics Symposium
JAK ‘Be Nimble’: New Applications of JAK Inhibitors in Dermatology
Stuart D. Shanler, MD co-founded Aclaris Therapeutics, Inc. and has served as their Chief Scientific Officer since their inception in July 2012. Between July 2011 and July 2012. Dr. Shanler co-invented a topical rosacea drug for, and co-founded and served as Chief Scientific Officer of Vicept Therapeutics, Inc. from 2009 until its acquisition by Allergan, Inc. in July 2011. Previously, Dr. Shanler was a dermatologic surgeon in private practice. Dr. Shanler is a board-certified dermatologist and received his M.D. degree from Albany Medical College of Union University and received B.S. degrees in Biology and the Biological Basis of Behavior from the University of Pennsylvania.